The global Biopreservation Market size reached USD 8.5 Billion in 2024. It is expected to grow to USD 20.0 Billion by 2033, exhibiting a CAGR of 9.98% during the forecast period of 2025-2033. The market growth is driven by the rising focus on personalized medicine, increasing R&D investments, and growing awareness about rare diseases. Biopreservation techniques enable long-term preservation of biological materials for applications in research, clinical use, and industrial processes.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
Biopreservation Market Key Takeaways
- Current Market Size: USD 8.5 Billion in 2024
- CAGR: 9.98% during 2025-2033
- Forecast Period: 2025-2033
- The market is primarily driven by personalized medicine and increased R&D investments by governments and private entities.
- Rising awareness and understanding of rare diseases foster demand for preserved biological samples for diagnostics and targeted therapies.
- Advancements in cryoprotectants, automated systems, and enhanced storage protocols improve preservation efficiency and safety.
- Growing demand for biobanking facilitates large-scale clinical trials, genomic testing, and biomarker discovery.
- Expansion of biopharmaceuticals requires stable preservation methods to maintain biological drug efficacy throughout their lifecycle.
Sample Request Link:Â
https://www.imarcgroup.com/biopreservation-market/requestsample
Market Growth Factors
The growth of the biopreservation market is propelled by the increasing demand and development in personalized medicine. As the report highlights, an expanded focus on personalized treatments and drug development fuels the need for reliable biopreservation techniques that maintain biological material integrity over extended periods. These techniques enable researchers and clinicians to store cells, tissues, and organs essential for developing novel therapies and diagnostics.
Investments in research and development (R&D) activities by governments, academic institutions, and private organizations greatly benefit the market. Such investments support advancements in life sciences, biotechnology, and healthcare fields. The report underscores that these growing R&D efforts enhance biopreservation capabilities through new cryoprotectants, automated storage systems, and improved protocols, thereby further expanding usage and market potential.
The rising awareness and understanding of rare diseases and genetic disorders among populations are significant drivers of biopreservation demand. The report reveals an increasing need to preserve biological samples from affected individuals, enabling the study of disease mechanisms, diagnostics development, and targeted therapy facilitation. This expanding awareness contributes to the global growth and application of biopreservation technologies.
Market Segmentation
Product Type:
- Biopreservation Equipment: Specialized devices and instruments for cryopreservation, vitrification, lyophilization, and chemical fixation; essential for preserving viability and integrity of biological samples. Dominates the market due to high demand in genomics, personalized medicine, and drug development.
- Biopreservation Media: Also called cryopreservation or storage media, contains cryoprotectants, osmotic agents, antioxidants, and nutrients to protect cells during freezing and storage, ensuring post-thaw viability.
Application:
- Therapeutic Applications: Use of biopreservation for cells and tissues in transplantation, regenerative medicine, and therapies.
- Biobank Applications: Storage and management of large collections of biological samples for research, diagnostics, and clinical usage. This segment holds the largest market share.
- Drug Discovery Applications: Preservation of cell lines and tissue samples is essential for screening and testing during the drug discovery process. Supports high-throughput screening and accelerates drug development.
Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Regional Insights
North America is the dominant region in the biopreservation market, holding the largest share. This leadership stems from the presence of advanced healthcare infrastructure, prominent medical research institutions, and well-established biotechnology and pharmaceutical industries. A robust network of government-funded, academic, and private biobanks further supports market demand. Standardized biobank practices and infrastructure contribute to North America’s clear market dominance.
Recent Developments & News
In June 2023, BioLife Solutions, Inc. launched a new large-capacity controlled-rate freezer (CRF) to support high-volume cell therapies and commercial-scale manufacturing. In January 2023, Thermo Fisher Scientific Inc. completed its acquisition of The Binding Site Group to expand its specialty diagnostics portfolio, including innovations in multiple myeloma diagnostics. PHC Holdings Corporation acquired the remaining 30% stake in its subsidiary SciMed (Asia) Pte. Ltd., making it a wholly owned subsidiary to boost its life sciences business in the Asia-Pacific region.
Key Players
- BioLife Solutions, Inc.
- Thermo Fisher Scientific Inc.
- VWR International, LLC
- Panasonic Corporation
- BioCision LLC
Ask For Report Customization:
https://www.imarcgroup.com/request?type=report&id=829&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
